These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23717829)

  • 1. Authors' response to 'TAP deficiency is also a cause of bronchiectasis'.
    Whitters D; Stockley RA
    Thorax; 2013 May; 68(5):491. PubMed ID: 23717829
    [No Abstract]   [Full Text] [Related]  

  • 2. TAP deficiency is also a cause of bronchiectasis.
    Zimmer J; Sleiman M; Poli A; Michel T; Hentges F
    Thorax; 2013 May; 68(5):490-1. PubMed ID: 23299963
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunity and bacterial colonisation in bronchiectasis.
    Whitters D; Stockley R
    Thorax; 2012 Nov; 67(11):1006-13. PubMed ID: 21933944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Plasmapheresis in Patients with Bronchiectasis with Pseudomonas aeruginosa Infection and Inhibitory Antibodies.
    Wells TJ; Davison J; Sheehan E; Kanagasundaram S; Spickett G; MacLennan CA; Stockley RA; Cunningham AF; Henderson IR; De Soyza A
    Am J Respir Crit Care Med; 2017 Apr; 195(7):955-958. PubMed ID: 28362198
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for
    Skopelja-Gardner S; Theprungsirikul J; Meagher RE; Beliveau CM; Bradley KE; Avery M; Henkle E; Siegel S; Gifford AH; Winthrop KL; Rigby WFC
    Eur Respir J; 2019 Feb; 53(2):. PubMed ID: 30385530
    [No Abstract]   [Full Text] [Related]  

  • 6. Moving Beyond Antibiotics: Exploring the Potential of an Antivirulence Monoclonal Antibody against
    Crabbé A
    Am J Respir Crit Care Med; 2024 Jul; 210(1):8-9. PubMed ID: 38780075
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical impact of
    Pieters A; Bakker M; Hoek RAS; Altenburg J; van Westreenen M; Aerts JGJV; van der Eerden MM
    Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30635292
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis.
    De Soyza A; Perry A; Hall AJ; Sunny SS; Walton KE; Mustafa N; Turton J; Kenna DT; Winstanley C
    Eur Respir J; 2014 Mar; 43(3):900-3. PubMed ID: 24176999
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term treatment with azithromycin in a patient with idiopathic bronchiectasis].
    Máiz Carro L
    Arch Bronconeumol; 2005 May; 41(5):295. PubMed ID: 15919012
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of
    Vallières E; Tumelty K; Tunney MM; Hannah R; Hewitt O; Elborn JS; Downey DG
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404646
    [No Abstract]   [Full Text] [Related]  

  • 11. The Microbial Endocrinology of Pseudomonas aeruginosa: Inflammatory and Immune Perspectives.
    Yong VFL; Soh MM; Jaggi TK; Mac Aogáin M; Chotirmall SH
    Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):329-339. PubMed ID: 29541797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis.
    Suarez-Cuartin G; Smith A; Abo-Leyah H; Rodrigo-Troyano A; Perea L; Vidal S; Plaza V; Fardon TC; Sibila O; Chalmers JD
    Respir Med; 2017 Jul; 128():1-6. PubMed ID: 28610665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low transmission risk of
    Cramer N; Sedlacek L; Tümmler B; Welte T
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30635293
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic bronchial infection: the problem of Pseudomonas aeruginosa].
    Cantón R; Fernández Olmos A; de la Pedrosa EG; del Campo R; Antonia Meseguer M
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():8-13. PubMed ID: 21703473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection.
    Lin CK; Kazmierczak BI
    J Innate Immun; 2017; 9(3):250-261. PubMed ID: 28222444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic obstructive pulmonary disease and bronchiectasis.
    Novosad SA; Barker AF
    Curr Opin Pulm Med; 2013 Mar; 19(2):133-9. PubMed ID: 23287285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis.
    Davies G; Wells AU; Doffman S; Watanabe S; Wilson R
    Eur Respir J; 2006 Nov; 28(5):974-9. PubMed ID: 16899482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against Pseudomonas aeruginosa in patients with bronchiectasis: helpful or harmful?
    Høiby N
    Thorax; 2001 Sep; 56(9):667-8. PubMed ID: 11514683
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical implication and management of Pseudomonas aeruginosa colonization in patients with bronchiectasis].
    Xu JF; Chai YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jul; 42(7):506-509. PubMed ID: 31365966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-neutrophil cytoplasmic antibodies (ANCA) in serum and bronchoalveolar lavage fluids of cystic fibrosis patients and patients with idiopathic bronchiectasis.
    Cobanoğlu N; Ozcelik U; Cetin I; Yalçin E; Doğru D; Kiper N; Bakkaloğlu A
    Turk J Pediatr; 2010; 52(4):343-7. PubMed ID: 21043377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.